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Developing the clinical components of a complex
intervention for a glaucoma screening trial:
a mixed methods study
for The Glaucoma screening Platform Study group
Abstract
Background: Glaucoma is a leading cause of avoidable blindness worldwide. Open angle glaucoma is the most
common type of glaucoma. No randomised controlled trials have been conducted evaluating the effectiveness of
glaucoma screening for reducing sight loss. It is unclear what the most appropriate intervention to be evaluated in
any glaucoma screening trial would be. The purpose of this study was to develop the clinical components of an
intervention for evaluation in a glaucoma (open angle) screening trial that would be feasible and acceptable in a
UK eye-care service.
Methods: A mixed-methods study, based on the Medical Research Council (MRC) framework for complex
interventions, integrating qualitative (semi-structured interviews with 46 UK eye-care providers, policy makers and
health service commissioners), and quantitative (economic modelling) methods. Interview data were synthesised
and used to revise the screening interventions compared within an existing economic model.
Results: The qualitative data indicated broad based support for a glaucoma screening trial to take place in primary
care, using ophthalmic trained technical assistants supported by optometry input. The precise location should be
tailored to local circumstances. There was variability in opinion around the choice of screening test and target
population. Integrating the interview findings with cost-effectiveness criteria reduced 189 potential components to
a two test intervention including either optic nerve photography or screening mode perimetry (a measure of visual
field sensitivity) with or without tonometry (a measure of intraocular pressure). It would be more cost-effective, and
thus acceptable in a policy context, to target screening for open angle glaucoma to those at highest risk but for
both practicality and equity arguments the optimal strategy was screening a general population cohort beginning
at age forty.
Conclusions: Interventions for screening for open angle glaucoma that would be feasible from a service delivery
perspective were identified. Integration within an economic modelling framework explicitly highlighted the trade-
off between cost-effectiveness, feasibility and equity. This study exemplifies the MRC recommendation to integrate
qualitative and quantitative methods in developing complex interventions. The next step in the development
pathway should encompass the views of service users.
Background
Complex interventions are widely used in the health ser-
vice context but are well known to be difficult to develop
and evaluate [1]. In the development phase the likely
mechanism of action for the intervention should be
understood with consideration given to implementation
at an early stage (by consulting with key stakeholders)
and to model the potential costs and effects of the pro-
posed intervention. These factors can then be used to
inform decisions such as whether a full scale trial would
be appropriate or not (e.g. trial would have to be unfeasi-
bly large; interventions are not likely to be cost-effective).
The guidance by Craig and colleagues[1] highlights the
potential of mixed methodologies to achieve these aims,
in particular the role of qualitative enquiry to articulate
the intervention’s complexity, and the use of quantitative
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modelling to identify configurations of complex services
that could potentially be cost-effective early in the devel-
opment pathway. However, there are limited reports of
how this augmented approach has been applied in prac-
tice. This paper presents the first phase of the develop-
ment of a complex intervention for a potential national
glaucoma screening trial for open angle glaucoma.
Glaucoma is a leading cause of avoidable blindness
worldwide [2], and second to macular degeneration is
the most common cause of blindness in the UK [3].
Open angle glaucoma is the most common form of
glaucoma [2] and early detection and treatment is effec-
tive at reducing progressive disease [4,5]. However, the
current UK practice of opportunistic case finding delays
identification of the majority of cases [6] and late detec-
tion is a major risk factor for glaucoma blindness [7,8].
The two main reasons for under detection of glaucoma
are poor uptake of community eye care services by
members of the public [9-11] or missed cases by pri-
mary eye care services[12-15]. Based on the public
health importance of glaucoma, it has been considered
as a condition that might merit a population based
screening programme. However, prior to initiating a
screening programme several criteria need to be met
concerning the condition, the test, the treatment and
the screening programme. Importantly any benefits of
screening must outweigh potential harms [16].
The UK National Screening committee (UKNSC), the
body that advises the NHS on screening policy, consid-
ered glaucoma against these criteria in 2006 and con-
cluded that there was insufficient evidence to
recommend glaucoma screening, but that further
research was required [17]. A health technology assess-
ment (HTA) review was commissioned to inform a sub-
sequent policy review on glaucoma screening. The HTA
report [6] identified that no randomised controlled trials
(RCTs) had been conducted to evaluate the effectiveness
of glaucoma screening for reducing sight loss [18]. The
economic modelling showed that any general population
screening programme, based on age selection alone, was
unlikely to be cost-effective (given current decision-
making criteria in the UK [19]), but that ‘targeted’
screening of high risk groups may be. However, due to
the limited primary data available, further research was
advocated to test the model estimates and inform deci-
sions about best practice for screening [20]. A separate
HTA report, conducted in Finland, concluded that an
organised screening programme for glaucoma could be
a cost-effective strategy, and, in contrast to the report
by Burr and colleagues [6,20] that screening was more
likely to be cost-effective in older age groups [21]. The
differences in conclusions were driven by differences in
model structure and costs. Specifically, in the Finnish
model the assumed gain in quality of life due to
screening preventing inappropriate treatment (and
hence side effects of treatment) in the elderly was a
main driver for the cost-effectiveness of screening.
Prompted by the continuing uncertainty around
whether to progress with a screening programme (and
by the acknowledged public health importance of glau-
coma), the international ophthalmic community has
called for a high quality study evaluating population
screening for glaucoma versus the current practice of
opportunistic case finding [22-25]. Designing a high
quality RCT of a screening intervention for open angle
glaucoma presents particular challenges including:
which screening test to use and who should administer
it; where to locate the screening; which population to
target; how to identify individuals in the target popula-
tion; how to maximise attendance for screening; and
how potential harms and benefits of screening in the
glaucoma context should be considered.
The aim of this study was to inform the development
of a glaucoma screening intervention that would be fea-
sible and acceptable both in terms of service delivery
and cost-effectiveness in a UK health service context.
We explored opinions representing a service provider
and policy perspective, namely eye-care providers, policy
makers and health service commissioners, on the most
feasible and acceptable components (target population,
site, screening tests and operator) of glaucoma screening
strategies. These insights provide key information to
refine and revise an economic model initially developed
by Burr and colleagues[6,20].
Methods
We used an integrated qualitative and quantitative
methods design. There are many screening tests and
combinations of tests, test operators and screening loca-
tions that could be used in a glaucoma screening pro-
gramme. Possible screening tests were identified and
evaluated in a previous systematic review of screening
test performance [26]. No single test or combination of
tests was clearly superior. Selection of an optimal test or
test combination therefore rests on the feasibility and
acceptability to both users and service providers. A Del-
phi survey, developed from the previous HTA review
and the review of screening test performance [6,20],
with a sample of glaucoma experts worldwide, informed
a reduced set of potential screening tests and testing
arrangements. The findings from the Delphi study are
being written up elsewhere; in brief, there was some
agreement on the age of fifty to initiate screening in a
primary care setting with ophthalmic trained technical
assistants (hereafter referred as ‘technicians’) delivering
the screening tests; however a wide range of screening
tests and combinations of tests were selected with no
agreement on what would be a suitable screening test.
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To determine the feasibility and acceptability of a
range of possible tests and testing arrangements in a UK
National Health Service context we:
a) undertook semi-structured interviews with eye-
care providers, policy makers and health service
commissioners to elicit their experiences and per-
spectives about the main properties of a potential
intervention for a national glaucoma screening trial;
and
b) assessed the likely cost-effectiveness of proposed
test strategies.
Detailed methods are presented below.
Elicitation of provider perspectives on a potential
screening intervention
Recruitment and sampling
The purposive sample for this qualitative component
was selected to represent a wide range of health profes-
sionals including ophthalmologists, optometrists, general
practitioners (GPs), nurses, technicians and directors of
public health from across the UK (target numbers,
together with numbers interviewed, are presented in
Table 1). We liaised with Vision 2020 UK (an umbrella
organisation focusing on visual impairment and aiming
to facilitate greater collaboration and co-operation
between organisations within the UK [27]), the relevant
specialist royal colleges, the UKNSC, and the National
Diabetic Retinopathy Screening Programme to facilitate
purposive recruitment of a wide range of expert groups
from the different organisational sites across the UK.
Where possible, we included individuals working in
urban and rural areas to reflect a broad range of provi-
sion. The leads of these organisations contacted mem-
bers by email, providing a brief summary of the project
and inviting them for interview. From this we received a
list of potential participants as follows: 28 ophthalmolo-
gists, 31 optometrists, 6 GPs, and 12 nurses, whom we
contacted by telephone and email to discuss the study
in more detail, obtain informed consent and to arrange
a suitable interview time. As is common in recruitment
practice, we also received a small number of participants
through the snowballing method - in particular leading
to contacts in the ‘technician’ group (ophthalmic photo-
graphers and perimetrists) and with policy makers. In
total we recruited a purposive sample of 46 (Table 1).
Respondents were given the choice of telephone inter-
views or face-to-face interviews (to minimise bias on the
basis of geographical accessibility).
Interviews
Interviews were conducted by three qualitative research-
ers (AG, DH, SM) and took place between January-
October 2009. The focus of the interviews was on inter-
viewees’ perspectives about the main properties of their
preferred screening trial intervention, specifying key
Table 1 Interview respondent characteristics by profession, geographic and organisational designation
Provider Group No.
sought
No.
interviewed
Location/organisational designation of interviewees
Ophthalmologists 10 13 England: working in Hospital Eye Service (HES) in general hospital (8) working in specialist
eye hospitals (3)
Scotland: working in HES in general hospital (2)
Optometrists 10 12 England: working in HES in general hospital (3)working in high street (2) working in both
HES (general hospital) and high street (1) working in high street and as academic
optometrist (1)
Scotland: working in high street (2) working in high street and in HES in a general hosp (1)
Wales: working in high street (1)
Northern Ireland: working in high street (1)
Nurses 10 5 England: working in HES (1) working in specialist hospital (1)
Scotland: working in HES (1) working in Diabetic Retinopathy Service (1) + a nurse with a
shared remit for England and Scotland: working in voluntary sector
General Practitioners 10 4 England: practicing GP with a special interest in ophthalmology (1)
Scotland: practicing GP also working as a clinical assistant in ophthalmology (HES) (1)
practicing GP and academic GP (1) practicing GP with special interest in ophthalmology (1)
Technicians 5 3 To protect respondents’ anonymity geographical location is not indicated here. Two medical
photographers and one tester/grader
Policy, commissioning,
planning and strategy
12 9 England: planning, policy development (4)
Scotland: public health consultant, commissioners of public health services, clinical services
(3)
England and Scotland: joint remit for eye health prevention and policy working in
voluntary sector (2)
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criteria for feasibility and acceptability in a service con-
text. In particular, we explored the reasons for the vary-
ing opinions around the choice of a screening test, and
the broader contextual background to interviewees’ opi-
nions, as a way of identifying external factors that might
be anticipated to impact on implementation. The pur-
pose of this was to optimise the design of the
intervention.
Data handling and analysis
Interviews were recorded, transcribed verbatim and
anonymised. Field notes were taken during the inter-
views and immediately afterwards. We undertook a the-
matic qualitative analysis in accordance with constant
comparative techniques derived from grounded theory
[28]. We coded transcripts independently and jointly to
identify common themes. Data analysis was a continu-
ous iterative process with categorisation refined to
reflect new themes and variations on existing themes. A
thematic framework was developed consisting of six
higher order themes, and two subsidiary branches.
To present the data in its most accessible form and to
assist its utilisation in the synthesis with the subsequent
phase of the project, we presented the data in two parts.
The first part presented a systematic summary of opi-
nions about preferred components of the intervention
the screening properties - nominated tests, locations,
test operators and diagnostic pathways (illustrated in
Table 2). The second part presented an interpretative
analysis of the broader implementation concerns - nota-
bly policy, institutional and organisational issues. Hand-
ling the substantial amount of data in this way
facilitated the synthesis and integration of data into the
economic model. Presenting the data in this way was, of
necessity, a simplification of the full accounts; however,
care was taken to ensure that the underlying relation-
ships and links in the data were retained.
Economic modelling
One criterion used to judge whether an intervention
should be taken forward to trial is whether it can poten-
tially be cost-effective. The original economic model,
[20], compared the cumulative costs and benefits (mea-
sured in clinical terms and quality adjusted life years) of
two screening interventions with current practice. The
model did not include a detailed specification of the
screening tests but, due to the uncertainty regarding the
optimal screening tests, incorporated the screening test
performance of hypothetical tests. The summary data
produced by the qualitative interviews provided new
information to define further alternative screening stra-
tegies which in turn could be compared with current
practice and tested in the economic model. For example,
if an interviewee mentioned two potential alternative
sites where screening could be conducted in a trial plus
two alternative set of tests, four potential alternative
screening strategies were thus deemed available for con-
sideration within the economic model.
On the basis of the outputs from this model, the new
screening strategies were then ordered according to the
potential that they would be cost-effective. The ordered
list of all possible trial screening strategies was reviewed
by the multidisciplinary project management group
(including ophthalmologists, statisticians, health econo-
mists, health psychologists and sociologists) with a view
to identifying the most likely candidate strategy to take
to trial. Likelihood was judged primarily on cost
Table 2 Two examples of summaries of screening specifications representing diversity of provider views
Screen
location
Screen
operator
Target
population
Screen tests Criteria
for screen
positive
Diagnostic site
for screen
positives
Diagnostic assessor Diagnostic test
Community
(General
Practice or
optometry,
or van in
remote
areas)
Optometrist
or
technician
60 Tonometry [GAT] +
nerve fibre layer
imaging [expressed
preference for GDx as
the nerve fibre layer
imaging analysis
technology] + perimetry
[expressed a preference
for Humphrey 24-2 and
a strong dislike of FDT]
± anterior chamber
depth [UBM].
Didn’t say Virtual clinic:
Information
from screen
positives read
by consultant
ophthalmologist
Consultant
ophthalmologist
[strong dislike of this
expert job being
done by dedicated
technicians, nurses,
nurse consultants]
Reading of screen test
information and then
either discharged, retest
or those reading positive
referred for full standard
care glaucoma work up
and decision regarding
treatment.
General
Practice
health
centre
Nurse/
technician
or GP or self
testing
50 but
younger for
African
Caribbean
ethnic
groups
Ideally simple visual
function test taking 2-3
minutes on laptop
computer [Motion
Detection Perimetry]
and tonometry
Difficult to
determine
a cut -off
threshold
for IOP
HES Expert Full Glaucoma workup
HES: Hospital Eye Service IOP: Intraocular pressure GDx: Scanning laser perimetry
FDT: Frequency Doubling Technology UBM: Ultrasound biomicroscopy GAT: Goldmann Applanation Tonometry
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effective criteria but also considering feasibility criteria
such that if screening were effective the interventions
could be implemented into UK eye care services. In
addition, the group also considered interventions that
posed special circumstances e.g. interventions that:
a) could be developed from the non cost-effective
alternatives that were not already considered in the
table. For instance, if an interviewee mentioned a
very high skilled operator together with a low cost
set of tests while another stated a low skilled opera-
tor together with a very costly set of tests; these
could be redeveloped into an alternative that looked
more likely to be cost-effective (e.g. non-skilled
operator together with a low cost set of tests).
b) were possibly cost-effective but were unrealistic
(e.g. where a non skilled operator was mentioned
together with a test for which a highly skilled opera-
tor was needed).
c) would be useful to consider in terms of their
acceptability to patients and the public, and included
tests in an early stage of development but likely to
be candidate screening tests for evaluation in further
research.
This study was classified as a service evaluation and
did not require national research ethics committee
approval (as advised by the North of Scotland Ethics
Committee). We certify that all applicable institutional
and governmental regulations concerning the ethical use
of human volunteers were followed during this research.
Results
Interviews
The findings from the interviews identified many differ-
ing opinions on the choice of screening test (s), consis-
tent with the prior Delphi study. The qualitative data
provided insights into the difficulties agreeing on the
screening test(s) and provided insights into how a
screening intervention could be tailored according to
particular groups who might not access eye care ser-
vices. Of particular interest, and relevant to the potential
implementation of a future screening programme, was
concerns about professional tensions between expert
provider groups in eye care services, and these concerns
were reflected in their respective discussions about the
feasibility and acceptability of the component parts (test,
site, target population) of the intervention.
Preferred site
Most interviewees agreed that screening should take
place in a primary care setting. Some thought that capi-
talising on current organisation and infrastructure in
primary care, either in high street optometry or general
practice, made most sense, although this was caveated
by concerns about the business ethos of high street
optometry, and how this may present a barrier to
recruiting high risk groups:
’That’s (private eye care services) probably going to
gradually increase in a way because the likes of ...
[specific company names], all the cheap and nasty
services... they model and they tell their optometrists
that they are expected to convert 80% of the people
they see into a pair of glasses which means there’s no
wasting time with repeating examinations and doing
the things that ... they may wish to do, you know
time is money, you are here to flog glasses mate, get
on with it, and that’s very much ... the growing Busi-
ness model’. (Ophthalmologist)
The reality of the commercial influences defining high
street optometry featured in optometrists’ responses.
Currently there is variation among UK devolved admin-
istrations as to remuneration procedures for ‘high street’
(community) optometrists providing eye care services,
with optometrists in Scotland currently receiving con-
siderably more than optometrists in other areas of the
UK:
’Currently there’s no real incentive for optometrists to
do it, so it’s not a pre-requisite to get involved in
glaucoma management or enhanced screening. ’
(Optometrist, England)
Some interviewees identified the positive appeal that
placing general practitioners as key players in the pro-
gramme represented. However, it was recognised that
this was mitigated in practice by general practitioners’
retreat from primary eye health, as government policy,
and indeed the public, has increasingly identified opto-
metry as the primary provider site of eye services in the
community:
“...so on the one hand there’s this move and I think a
number of patients are getting used to it and accept-
ing it, that when they’ve got an eye problem they go
to the optician, they don’t come to the GP. And it
would kind of seem counterintuitive if then you’ve got
this new system aimed at eye conditions which has
gone back in GP surgeries, do you see what I mean?”
(Practicing and academic GP)
The use of a mobile van was commonly endorsed as
was the suggestion that the diabetic retinopathy screen-
ing service could be used as a possible template for
glaucoma screening or indeed, that glaucoma screening
could be piggybacked onto the existing screening for
retinopathy.
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Target population
A minority of interviewees highlighted the need for any
screening programme to be directed towards the hard-
to-reach groups, such as African and Caribbean ethnic
groups. However, a larger number of the interviewees
disagreed with this targeted approach - their own
experiences as practitioners left them wondering
whether it would be fairer to screen the whole popula-
tion to ensure that no one with glaucoma was missed
out. The dilemma that arose, therefore, was that what
appeared to be the most cost-effective option [the tar-
geted approach] was not necessarily the fairest choice,
in terms of access to services. Below is an example of a
respondent calling for a targeted approach to screening:
’We need to focus particularly our attentions on
populations of people from black ethnic minority
groups who have a higher susceptibility to certain eye
disease and also to people on low incomes, those folk
are furthest from engagement with the eye care sector’
(policymaker)
Whereas another interviewee acknowledged the lim-
ited evidence to make judgements on whom to screen
illustrating a difference in opinion between policy
makers and providers:
’I think that’s [universal screening at age 50] as good
as anything because we’ve got very little data about
what will happen if you go out to the community
screening glaucoma. You don’t know what’s happen-
ing’ (ophthalmologist)
Preferred Test(s) and preferred operator
Interviewees found it difficult to differentiate between
identifying test(s) relevant for a screening intervention
(ie a test to initially identify those more likely to have
glaucoma) and those for the full diagnosis of glaucoma.
Clinicians generally stressed the necessity of using three
tests - visual field examination, measurement of intrao-
cular pressure and imaging of the optic nerve - which
reflects the practice of a diagnostic strategy used by
many of the interviewees. A number also pointed out
that the clinical grounds for recognition of glaucoma
has undergone a revision, from one based on raised
intraocular pressure to one that includes optic neuropa-
thy:
’’Optometrists... the training has improved and....also
the dependence on intraocular pressure has been the
main criteria. That has sort of shifted more towards
visual fields and optic discs. I say it in that order
because they still aren’t very good at looking at optic
discs. You know, but they do visual fields and they
attempt to have a look at the optic disc..... and that has
improved the detection rate. In time I think it’s
increased the number of false positives being referred to
secondary care quite dramatically...."(Ophthalmologist)
Discussions about preferred tests highlighted differ-
ences in opinions between the two main clinical provi-
der groups, ophthalmologists and optometrists. While
clinician groups generally agreed that optometrists
should have a key role in the delivery of tests, the
majority indicated that the role of optometrists was to
‘moderate’ between the trained technical operators and
the expert ophthalmic diagnostic role.
Overwhelmingly, and primarily out of financial consid-
eration, clinicians suggested that ‘technicians’ supported
by optometrists trained in glaucoma detection, repre-
sented the optimum choice of test operator. There were
concerns raised, however, about ensuring adequate
training for both technicians and optometrists - training
together with quality assurance were identified as
resource intensive essentials in any future screening
trial. Unfortunately it was difficult to explore this in
more detail as we had difficulties recruiting ‘technicians’
working in ophthalmic services to the study. Of the
eight technicians we approached to take part only three
were willing to be interviewed. However, we did have
informal telephone discussions with a small number of
technicians (who declined to formally participate in the
study) who indicated their concerns regarding the lack
of career structure for technicians, and the already
intense workload that they experienced for little remu-
neration in often poor working conditions. This they
saw as working against the premise that, in practice,
there would be adequate technicians available, and com-
mitted to, resourcing a massive explosion of their work-
load should a screening programme be initiated. Their
insights echoed those concerns expressed by the for-
mally recruited technician group of respondents.
A number of optometrists (especially those who had
combined primary and secondary care careers) raised
concerns about the structural factors mitigating against
high-street optometrists being able to access courses on
glaucoma detection, notably that they received no
appropriate reimbursement for the cost of the courses
and time out of their commercial enterprises. Addition-
ally, a number pointed to Scotland as the country in the
UK where the interpretation of the optometrists’ con-
tract potentially provided more opportunity for specia-
lising in glaucoma.
Summary of the results of the interviews
The provider and policy perspectives regarding the con-
figuration of an intervention for a national glaucoma
screening trial indicated support for screening in pri-
mary care, using ‘technicians’ supported by optometrists.
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Potential barriers to implementation were identified. In
particular the interview findings highlighted many of the
complexities around a glaucoma screening programme
such as the ethical issues of adopting a targeted
approach to those in higher risk groups versus one of
universal population provision, or on strategic and/or
organisational grounds (priority setting in the NHS, ade-
quate resourcing) and the associated constraints of a
testing strategy. The study also flagged difficulties in
being able to definitively identify preferred test(s), pre-
ferred operator, location and target population ‘in prin-
ciple and in isolation’. Rather, the choice of each of
these configurations was seen to be dependent on a
range of contextual factors. In particular, interviewees’
opinions were influenced by their experiences of the
current context of professional and organisational ten-
sions in eye health services.
In summary:
• Preferred screening site was a primary care setting
• Preferred screening operator was a trained techni-
cian supported by a specialist optometrist
• Most interviewees thought that ultimately an
ophthalmic consultant must make the diagnosis of
glaucoma
• The preferred age to initiative screening was 50
years for the general population
• Most interviewees identified the ‘at risk’ groups as
those with a primary family history, and those of
African and Caribbean ethnic origin. Respondents
indicated that the age at which screening were to be
initiated should be under 50 for these risk groups.
• Potential intervention should have a low false posi-
tive rate
• Interviewees were aware of the finite resources of
the NHS and the limitations this posed on service
development, but nonetheless believed that a screen-
ing trial should occur because it could prevent peo-
ple going blind
• The commercial culture of high street optometry
was seen by many respondents as a barrier to cap-
turing at risk groups. Current professional tensions
between ophthalmologists and optometrists and
changes in the policy and organisational determi-
nants of eye care services that give optometrists
increasing professional autonomy back, influenced
respondents’ preferred screening intervention prop-
erties and their broader discussions.
• Many interviewees, while advocating a screening
trial, wanted the current infrastructure of case detec-
tion, referral refinement and shared care to be capi-
talised upon.
• Most ophthalmologists and optometrists in clinical
practice were adamant that the screening tests must
be based on current best clinical practice and that
simplifying this protocol for a screening context was
not acceptable practice
Economic assessment of likely cost-effectiveness
All the potential screening components (i.e. nominated
test(s), location(s), test operator(s), target population
and diagnostic pathway(s)) put forward by the intervie-
wees were summarised in tabular form for consideration
in the economic model [20]. A total of 189 screening
configurations were developed from interview data,
further illustrating the difficulty in identifying the clini-
cal components of a screening intervention. The multi-
disciplinary project management group (PMG) agreed
there were no additional relevant options that could be
developed from combination of components mentioned
by different interviewees (consideration a. - see methods
section). From this comprehensive list, a subset was
immediately rejected as candidates for a screening inter-
vention on the basis of known (from the previous
model) lack of cost-effectiveness; 57 because screening
required three or more tests (complex testing) or equip-
ment costing more than £25 per testing based on a
cost-effectiveness threshold of £20-30,000 per Quality
Adjusted Life Year gained and 40 on the basis that the
screening be undertaken by a highly trained health pro-
fessional. The original economic modelling evaluation
suggested that screening for glaucoma was only likely to
be cost-effective if the screening is targeted at forty year
olds with additional risk factors rather than general
population screening [20]; on this basis, a further 62
configurations which specified screening a general popu-
lation would have been ruled out. However, it was
apparent from the qualitative interviews that an equity
argument was voiced in favour of general population
screening and considerations should be given to screen-
ing in remote rural locations. Both cost-effectiveness
and equity arguments are likely to be important to deci-
sion-makers and taking into account the findings from
the economic model and the interviews the PMG agreed
that the 30 remaining configurations were realistic (con-
sideration b. - see methods section). Seven of the
remaining configurations considered a mobile unit as
the setting where screening would be conducted. We
considered this a variation of a primary care setting par-
ticularly relevant for remote areas. Key features of the
remaining 23 configurations were variations on screen-
ing location including ‘high street’ optometry or in gen-
eral medical practice. The tests were optic nerve
photography or perimetry (a measure of visual field sen-
sitivity) with or without tonometry (a device to measure
intraocular pressure), operated by paramedical staff (e.g.
nurse, technician or self-assessment, the latter being
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possible for perimetry available on Personal Computers
and self assessment tonometers.
Integrating the findings from the qualitative interviews
with the modelling thus identified the components of
the screening test intervention that could be implemen-
ted in a trial from a service perspective. These are gen-
eral population screening, for a cohort at age forty
(based on findings of the qualitative interviews of the
need to balance feasibility and equity with cost-effective-
ness criteria) in a primary health care setting. Screening
would be conducted by ophthalmic trained technical
assistants, undertaking optic nerve photography or
screening mode perimetry (a measure of visual field sen-
sitivity) with or without tonometry. The precise location
of screening a community setting would need to be tai-
lored to local circumstances illustrated by the suggestion
of using widely available eye care services e.g. the ‘high
street’ optometrist or mobile units for remote areas.
Discussion
This study identified screening interventions that eye care
service providers, policy makers and health service com-
missioners would find feasible and acceptable to use in a
trial of glaucoma screening and for implementation into
practice if screening was effective. The economic model-
ling component of this study ruled out candidate tests that
would be highly resource intensive and provided a short
list of candidate strategies that had the greatest potential
to be cost-effective. These involved testing in a primary
care setting (because they are embedded in the community
and have the infrastructure in place) delivered by techni-
cally trained personnel using a simple testing strategy - a
measure of intraocular pressure (a known risk factor for
glaucoma) [29], and either a measure of the visual field or
photography of the optic nerve.
The screening configurations identified in this study
meet one of the key principles of screening - that a sim-
ple, safe and affordable test is required before a screen-
ing programme can be implemented [30,16]. There is
tension, however, when determining the most appropri-
ate screening test, between a public health and a clinical
perspective. The public health perspective requires that
a screening test be sufficiently precise to distinguish
those who probably do and do not have the disease at
an acceptable cost, whereas the clinical view point often
tends towards the desire for precision and reliability.
There are many sophisticated imaging tests for diagnos-
ing glaucoma, but these are not affordable for a public
health intervention. Similarly, there are a variety of tech-
nologies to evaluate the peripheral visual fields. From
the currently available tests, fundus photography or sim-
ple visual field testing combined with a measure of
intraocular pressure meet the economic criteria. More
precise technologies or examinations would then be
required to examine those who screen positive. Cur-
rently, the recognition of glaucoma on fundus photogra-
phy is a skilled task and would require manual grading
by experienced observers. Automated grading systems
for retinal images have been developed for diabetic reti-
nopathy screening [31], and have been shown to be less
costly and as effective as manual grading [32]. Similarly,
there is potential for the development of automated sys-
tems for glaucoma recognition from retinal photographs
[33]. The performance of photography, with and without
automated grading, compared with simple visual field
testing would need to be compared within the interven-
tion arm in a future glaucoma screening trial or in a
parallel companion study. Screening tests suitable for
self-assessment are in the early stages of development,
and should be considered as an option when the tech-
nologies have advanced sufficiently.
This study is one of the first to show the formal inte-
gration of qualitative and quantitative methodologies (as
promoted in the MRC guidance) in the development of
a complex intervention and specifically the use of a qua-
litative enquiry to restructure the care pathways of an
economic model. The qualitative exploration enabled
agreement to emerge for some aspects of the proposed
intervention, whilst allowing reasons for disagreement to
be explored in-depth. The detailed information that
underpinned the lack of consensus (e.g. the disagree-
ments between the professional groupings) informs the
implementation planning for any of the proposed inter-
ventions, and aided interpretation of the results of the
economic analysis in particular highlighting that a more
universal coverage of screening all individuals above a
certain minimum age would represent a more appropri-
ate balance between equality of access and cost-effec-
tiveness. The economic modelling facilitated the
reduction of a wide selection of suggested interventions
to a shortlist representing those most likely to be cost-
effective. The study also brought together the perspec-
tives of a wide range of stakeholders (including ophthal-
mologists, optometrists, GPs, nurses, technicians and
policy makers) who would all have input into a screen-
ing programme for glaucoma, and this breadth of per-
spective adds to the veracity of our findings. Also, while
previous attempts to provide high quality evidence for
the case of screening for glaucoma have concentrated
on the technical and technological aspects of design,
evaluation and assessment, our research has also consid-
ered the implications of a screening programme on the
complex organisational context in which the manage-
ment of glaucoma exists.
Whilst our project was successful in facilitating the
development of an intervention for future testing in a
trial of glaucoma screening, it did have a number of lim-
itations. In particular, recruitment proved more difficult
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in practice than had been hoped. Whilst ophthalmolo-
gists and optometrists were easier to recruit, nurses,
technicians and general practitioners were more diffi-
cult. In the case of nurses and technicians, the difficulty
appeared to be related to confidence in speaking as one
who is located relatively low in the clinical ‘hierarchy’,
whilst difficulties in recruiting general practitioners’ in
research is well recognised [34]. Additionally, despite
the use of telephone interviews, we were unable to
recruit as many respondents with practice experience of
isolated and rural locations.
The MRC revised guidance outlines well the appropri-
ate steps for the development of a complex intervention
[1]. Integral to its tenets is the recommendation for the
synthesis of qualitative and quantitative methods, as well
as the need to consider implementation issues through
participants’ accounts of their perspectives and experi-
ences. The integration process, however, required signif-
icant iteration between the disciplinary approaches to
ensure that the qualitative data could be synthesised
into an economic model. The specification of particular
screening interventions was a challenge for the qualita-
tive researchers because this was not a standard way of
interpreting the data produced. Nevertheless, two com-
plementary mechanisms to synthesising the qualitative
data were used - firstly to systematically sort and
describe the respondents’ opinions about preferred com-
ponents of the intervention (to allow direct usage in the
economic model) and secondly to use the richness of
the data provided by the qualitative data to undertake
an interpretative analysis of the results of the economic
model and around the implementation considerations in
which the preferences were nested. The importance of
interplay between disciplines in mixed methods research
has been emphasised in the literature, particularly by
O’Cathain and colleagues [35].
We have identified screening strategies that are accep-
table in a service provider and policy context, but they
may not be acceptable to health care users. Additional
research is required to elicit the beliefs of health service
users regarding the acceptability of these screening
interventions and their current use of eye care services
to identify the most likely behaviour change interven-
tions for maximising attendance for glaucoma testing.
These findings will provide additional information, in
terms of potential uptake of any screening interventions
and current uptake of current eye care services, to be
integrated into the economic model to inform the feasi-
bility of any future glaucoma screening trial. This
research is underway.
Conclusions
This paper has highlighted how mixed methods research
can inform the development of an intervention for
screening for open angle glaucoma. It allowed the iden-
tification of screening interventions that could be imple-
mented in a UK health service context. Integration
within an economic modelling framework explicitly
highlighted the trade-off between cost-effectiveness, fea-
sibility and equity. The next step in the intervention
development is to seek the views of service users.
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